Ontario sees vaccine supply issues, Ottawa keeps AstraZeneca on the market - Canada News castanet.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from castanet.net Daily Mail and Mail on Sunday newspapers.
Pa. extends pause on Johnson & Johnson COVID vaccines
Updated Apr 15, 2021;
Pennsylvania is extending its pause of the use of the single-dose Johnson & Johnson coronavirus vaccine until April 24 or until there is updated federal guidance.
Federal health officials on Tuesday recommended the pause as they review the cases of six women, including a Pennsylvania woman, between the ages of 18 and 48, who had potentially serious blood clots 6 to 13 days after receiving the vaccine. This is a rare event as 6.8 million Americans have already received the Johnson & Johnson vaccine.
Pennsylvania initially recommended a pause until April 20 to give the Centers for Disease Control and Prevention and the Food and Drug Administration time to review the incidents of rare blood clots. The health department is now pushing that to April 24 or when the federal government issues new guidance.
OICR’s Drug Discovery Team is made up of 26 drug discovery scientists housed in state-of-art facilities with a mission to help Ontario’s researchers efficiently translate cancer related discoveries into novel oncology therapies. This team has “identified five of the most promising early stage oncology drug development projects in the province,” said Dr. Tom Hudson, the OICR’s president and scientific director. “OICR is pleased to support these Ontario-based research projects and we look forward to collaborating with our partners to help move them to the next stage of development,” he added.
The selected projects address a range of cancers, including hematological malignancies, triple negative breast cancer and colon cancer. They come from major institutions across Ontario and were selected from a province-wide call for proposals to identify promising oncology research that would benefit from OICR’s expertise in drug discovery.
Article content
Health Canada says rare blood clotting syndrome may be linked to AstraZeneca vaccine, but vaccine benefits far outweigh the risks.
Ottawa hospital admissions are doubling every 12 days and will soon outpace the health care systems ability to react, the city’s deputy medical officer of health warned Wednesday in a briefing to the Ottawa Board of Health.
We apologize, but this video has failed to load.
Try refreshing your browser. COVID-19: Ontario daily case count jumps back above 4,000 Back to video
“We are really not in a good place here and things could go very, very badly here in Ottawa in the next few weeks,” Dr. Brent Moloughney stressed.
Dr Daniel Andreae selected as Top Health Advocate and Health Educator of the Decade by IAOTP prunderground.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prunderground.com Daily Mail and Mail on Sunday newspapers.